HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

IDS 23

a stinging nettle extract that inhibits lipopolysaccharide stimulated monocyte cytokine expression

Also Known As:

IDS-23; Rheuma-Hek

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - IDS 23: 3
Pharmaceutical Preparations
- Plant Extracts: 3916
  - IDS 23: 3

Experts

1.	Itani, Yoshio: 1 article (01/2013)
2.	Ito, Kimihiko: 1 article (01/2013)
3.	Kanazawa, Riichiro: 1 article (01/2013)
4.	Takeuchi, Satoshi: 1 article (01/2013)
5.	Toyoda, Shinji: 1 article (01/2013)
6.	Tsubamoto, Hiroshi: 1 article (01/2013)

Related Diseases

1.	Residual Neoplasm 01/01/2013 - "After IDS, 23 patients had no macroscopic residual tumor. "
2.	Rheumatic Diseases (Rheumatism) 04/01/1996 - "An extract of Urtica dioica folium (IDS 23, Rheuma-Hek), monographed positively for adjuvant therapy of rheumatic diseases and with known effects in partial inhibition of prostaglandin and leukotriene synthesis in vitro, was investigated with respect to effects of the extract on the lipopolysaccharide (LPS) stimulated secretion of proinflammatory cytokines in human whole blood of healthy volunteers. "
3.	Autoimmune Diseases (Autoimmune Disease) 12/01/1999 - "IDS 23 may inhibit the inflammatory cascade in autoimmune diseases like rheumatoid arthritis."
4.	Rheumatoid Arthritis 12/01/1999 - "IDS 23 may inhibit the inflammatory cascade in autoimmune diseases like rheumatoid arthritis."

Related Drugs and Biologics

1.	IDS 23
2.	Cytokines
3.	Leukotrienes
4.	Prostaglandins
5.	Lipopolysaccharides

Related Therapies and Procedures

1.	Therapeutics